JAN 06, 2016 3:15 PM PST

Beneficial Microbes Linked to Antibody Production

WRITTEN BY: Kara Marker
Over time humans evolved alongside a beneficial microbial community, called the microbiome. In return for a place to live, these microbiota help regulate digestion in the gut, compete with harmful pathogens for nutrients, and boost the immune system. In a recent study from the Icahn School of Medicine at Mount Sinai, scientists identified yet another role the microbiome plays in keeping their human hosts healthy.

Immunoglobulin A (IgA), a type of antibody, is produced by B lymphocytes of the immune system and congregates primarily in the inner lining of the mucosa in the intestines and lungs. In a new study published in the Journal of Experimental Medicine, Icahn School of Medicine scientists identified a link between IgA and the microbiome.

Using mouse models to isolate dendritic cells, the research team cultured the cells with immunoglobulin-producing B lymphocytes for 4-5 days. Dendritic cell work with lymphocytes upon infection, displaying antigens for them to recognize (The Rockefeller University).

The team saw the B lymphocytes produced IgA after growth, representing a process called IgA class switch recombination where B lymphocytes “acquire the expression of IgA” (Nature Reviews Immunology). However, upon observation mice without a healthy microbiome due to antibiotic treatment had a severely reduced population of IgA. These same mice experienced a surge of IgA production when fed lipopolysaccharide, a component of the bacterial cell wall that the immune system recognizes as pathogenic.

Without a population of beneficial bacteria to stimulate antibody creation, these “germ free” mice had no IgA to protect them.

These observations are further evidence of overuse and misuse of antibiotics in medicine and food production negatively impacting the natural balance of the cells in our body, both foreign (microbiome) and our own. Low levels of IgA could also be a factor in increasing prevalence of asthma and other allergies in regions where antibiotic use is rampant.

There is no telling what other roles the microbiome plays in regulating human health. More consequences of dysbiosis, a microbial imbalance, are sure to appear though, if antibiotic use continues without regulation.
 
 
Source: Icahn School of Medicine 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 12, 2020
Drug Discovery & Development
FEB 12, 2020
Does Traditional Chinese Medicine Work Against Coronavirus?
Over 45,000 cases of Wuhan Coronavirus have been reported globally, alongside over 1,100 deaths. Although over 4,700 peo ...
MAR 25, 2020
Health & Medicine
MAR 25, 2020
Boosting Your Immunity to Avoid COVID-19 Infection
With the COVID-19 pandemic at the forefront of most people’s minds, you might be wondering what you can do to keep ...
MAR 29, 2020
Cell & Molecular Biology
MAR 29, 2020
Learning More About Boosting Immunity in Older Adults
Older adults are more susceptible to infections and don't generate a robust immune response after a vaccination.
APR 02, 2020
Immunology
APR 02, 2020
Potential New COVID-19 Vaccine is Delivered by Patch
The coronavirus pandemic caused by SARS-CoV-2 is demanding the world's immediate attention.
APR 09, 2020
Drug Discovery & Development
APR 09, 2020
Does Hydroxychloroquine Really Work Against COVID-19?
Although US President Donald Trump is a strong supporter of antimalarial drug Hydroxychloroquine as a treatment for COVI ...
APR 22, 2020
Drug Discovery & Development
APR 22, 2020
Only 3% of COVID-19 Antibody Tests Approved by FDA
So far, only 3% of at least 90 COVID-19 antibody tests in the US have been approved by the Food and Drug Administration ...
Loading Comments...